You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Bulk Pharmaceutical API Sources for bepridil hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for bepridil hydrochloride

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free B5016_SIGMA ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 50088 ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 2351 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Bepridil Hydrochloride

Last updated: August 2, 2025

Introduction

Bepridil hydrochloride is a calcium channel blocker historically used to treat angina pectoris and arrhythmias. Despite its market decline in many regions, the compound continues to hold significance in pharmaceutical research and niche therapeutic areas. The sourcing of bulk active pharmaceutical ingredients (APIs), such as bepridil hydrochloride, is vital to pharmaceutical manufacturers, research institutions, and compounding entities. This article evaluates current API suppliers, discusses key factors influencing sourcing decisions, and identifies best practices within the evolving landscape of bepridil hydrochloride procurement.

Overview of Bepridil Hydrochloride as an API

Bepridil hydrochloride (C_26H_33ClN_2O_2 · HCl) is a synthetic, small-molecule API with anti-anginal and anti-arrhythmic properties. Its synthesis involves multiple steps with rigorous quality controls mandated by regulatory agencies such as the FDA and EMA. The API’s manufacturing and supply chain complexity influence sourcing options, cost, quality consistency, and regulatory compliance.

Global API Manufacturing Landscape for Bepridil Hydrochloride

The global production of bepridil hydrochloride predominantly occurs in countries with well-established chemical and pharmaceutical manufacturing sectors, including China, India, and certain European nations. These regions benefit from advanced chemical synthesis capabilities, cost advantages, and extensive export infrastructure.

Major API Suppliers and Manufacturers

  1. Chinese API Manufacturers

    China remains the dominant source for many APIs, including bepridil hydrochloride, owing to its expansive chemical manufacturing industry and lower production costs. Several Chinese manufacturers produce bepridil hydrochloride API, with some accredited by international regulatory agencies for GMP compliance. Key considerations include verifying supplier certifications, batch consistency, and regulatory filings.

  2. Indian API Suppliers

    Indian pharmaceutical manufacturers have gained prominence in API production, leveraging cost efficiencies and robust quality standards aligned with cGMP guidelines. Indian companies such as Aurobindo Pharma, Sun Pharmaceutical Industries, and Divi's Laboratories maintain facilities capable of producing bepridil hydrochloride APIs meeting international specifications.

  3. European and US Suppliers

    Given stringent regulatory environments, European and US-based suppliers are less common for bepridil hydrochloride due to higher production costs. However, a limited number of specialty chemical producers or outsourcing divisions within larger pharmaceutical companies may supply APIs compliant with local and international Good Manufacturing Practices (GMP).

Bulk API Procurement Trends

  • Vertical Integration: Large pharmaceutical companies prefer integrated supply chains, often manufacturing APIs in-house or through trusted partners.
  • Third-Party API Contract Manufacturing: Many firms source APIs via Contract Manufacturing Organizations (CMOs) with proven GMP compliance, ensuring quality and regulatory adherence.
  • Regulatory Considerations: Suppliers with comprehensive DMF (Drug Master File) filings, validated manufacturing processes, and proven quality control are preferred to streamline regulatory submissions and audits.

Key Factors in Selecting API Suppliers for Bepridil Hydrochloride

1. Regulatory Compliance and GMP Certification

Suppliers must adhere to Good Manufacturing Practices (GMP) and possess appropriate certifications such as ISO 9001. The existence of valid regulatory filings (e.g., DMF, TeDF) facilitates compliance and facilitates a smooth product approval process.

2. Quality and Purity Standards

High API purity (>98%) consistent batch-to-batch quality are essential. Certificates of analysis (CoA), batch records, and purity testing results are critical for verification.

3. Price and Supply Stability

Cost considerations influence procurement strategies, especially when sourcing large quantities. Long-term supply agreements with reliable vendors mitigate risks of shortages or supply chain disruptions.

4. Lead Time and Delivery Reliability

Timely delivery aligned with production schedules is critical. Suppliers with established logistics networks and inventory management systems provide strategic advantages.

5. Sustainability and Ethical Sourcing

Environmental, social, and governance (ESG) factors influence procurement decisions. Transparent sourcing practices and adherence to environmental standards are increasingly prioritized.

Challenges and Considerations in API Sourcing for Bepridil Hydrochloride

  • Regulatory Hurdles: The necessity for comprehensive documentation and compliance can prolong qualification processes.
  • Market Availability: Limited current production shipments due to the drug's diminished market presence may impact availability.
  • Quality Variability: Variability inherent in some bulk APIs necessitates rigorous due diligence and QC analysis.
  • Price Fluctuations: Fluctuations in raw material costs and geopolitical factors can influence API pricing.

Emerging Trends and Best Practices

  • Supplier Verification Programs: Implementation of audits and supplier qualification programs minimizes quality risks.
  • Strategic Sourcing: Diversification of suppliers to mitigate geopolitical and supply chain risks.
  • Regulatory Harmonization: Engaging with suppliers who maintain filings across multiple regions reduces regulatory hurdles during international distribution.
  • Investment in Quality Control: Ensuring comprehensive testing protocols and stability studies for sourced APIs.

Conclusion

The sourcing landscape for bepridil hydrochloride API remains geographically concentrated, primarily in China and India, driven by cost-efficiency and manufacturing capacities. Quality assurance, regulatory compliance, and supply chain reliability are paramount. Companies and research entities must carefully evaluate suppliers based on certifications, manufacturing practices, and logistical capabilities. As regulatory frameworks tighten and supply chain resilience becomes critical, strategic sourcing and supplier diversification will be essential in maintaining a stable supply of high-quality bepridil hydrochloride APIs.

Key Takeaways

  • Chinese and Indian manufacturers remain primary sources for bulk bepridil hydrochloride APIs, owing to their scalable production and cost advantages.
  • Rigorous evaluation of GMP compliance, quality standards, and regulatory filings is critical before engaging new suppliers.
  • Developing strong relationships with established, verified vendors enhances supply stability and regulatory adherence.
  • Diversifying suppliers and maintaining transparent supply chains can mitigate geopolitical and logistical risks.
  • Staying informed of emerging API manufacturing trends and regulatory changes can optimize sourcing strategies.

FAQs

  1. What are the main regions supplying bepridil hydrochloride API globally?
    China and India dominate the API manufacturing landscape, providing the majority of bulk bepridil hydrochloride due to their extensive chemical production infrastructure.

  2. How do regulatory standards impact API sourcing for bepridil hydrochloride?
    Suppliers must meet GMP standards and possess valid regulatory documentation like DMFs to ensure compliance, facilitate approvals, and support quality assurance.

  3. What are the key quality parameters to consider when sourcing bepridil hydrochloride API?
    Purity (>98%), potency, residual solvents, impurity profile, and batch-to-batch consistency are critical quality attributes.

  4. Are there US or European-produced sources of bepridil hydrochloride API?
    Limited; most sources are located in Asia. Certain certified specialty chemical companies in Europe or the US may provide APIs compliant with domestic regulations.

  5. What strategies can improve API supply chain resilience for bepridil hydrochloride?
    Diversifying suppliers, establishing long-term contracts, verifying supplier quality, and maintaining safety stock levels are effective strategies.


References

  1. [1] Pharmacopoeia and regulatory filings of manufacturing facilities – FDA, EMA, and equivalent authorities.
  2. [2] Global API manufacturing reports – IQVIA, EvaluatePharma.
  3. [3] Industry surveys on API sourcing and supply chain analysis.
  4. [4] Chinese and Indian pharmaceutical produce directories – Chinese Medicine and Chemical Industry Association, Indian Pharmaceutical Congress.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.